0001567619-23-001474.txt : 20230130 0001567619-23-001474.hdr.sgml : 20230130 20230130212500 ACCESSION NUMBER: 0001567619-23-001474 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230126 FILED AS OF DATE: 20230130 DATE AS OF CHANGE: 20230130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mayer Eldon C. III CENTRAL INDEX KEY: 0001686952 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36183 FILM NUMBER: 23570024 MAIL ADDRESS: STREET 1: RIGEL PHARMACEUTICALS, INC. STREET 2: 1180 VETERANS BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc. CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 361004130 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-279-9845 MAIL ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Celladon Corp DATE OF NAME CHANGE: 20041005 4 1 doc1.xml FORM 4 X0306 4 2023-01-26 0 0001305253 Eiger BioPharmaceuticals, Inc. EIGR 0001686952 Mayer Eldon C. III C/O EIGER BIOPHARMACEUTICALS, INC. 2155 PARK BLVD. PALO ALTO CA 94306 0 1 0 0 Ex VP & Chief Commerc. Officer Stock Option (Right to Buy) 1.37 2023-01-26 4 A 0 31500 0 A 2033-01-26 Common Stock 31500 31500 D The option vests as to 50% on the first anniversary of the January 26, 2023 grant date, and as to the remaining 50% on June 26, 2024, subject to the Reporting Person's continuous service as of each such date. The option vests in full upon a change in control of the Issuer. /s/ Eldon C. Mayer III 2023-01-30